The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

NB.1.8.1 is one of the latest variants of COVID-19, a "slightly upgraded version" of the LP.8.1 variant that is prominent ...

FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid ...

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as ...

Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...

Because an mRNA vaccine doesn't use the live virus, it cannot give someone COVID-19, according to the CDC. The mRNA also never enters the nucleus of the cell, meaning it does not affect or ...

One type of COVID-19 vaccine used widely in the U.S. was the messenger ribonucleic acid (mRNA) vaccine, in which a copy of the viral mRNA that encodes a viral protein, such as the SARS-CoV-2 spike ...

Fighting COVID-19 proved a boon to cancer research. Here's how scientists are using the same mRNA technology to attack tumors.

However, the COVID-19 pandemic gave them the unique opportunity to put their knowledge and tools to the test and develop the first working mRNA vaccine. The Pfizer/BioNTech and Moderna mRNA vaccines ...

The COVID-19 vaccine from this sa-mRNA platform targeted against the JN.1 variant is approved in Japan for immunization against COVID-19 in adults 18 years and older and is being sold under the ...

First, a COVID-19 mRNA vaccine is injected into a muscle in your upper arm. Some muscle cells take the mRNA instructions in the vaccine and make a harmless piece of a protein called a spike protein.